TRAC

TRAC Liste de produits

Attribut
Protein (2)
Bibliothèque de produits
En ligne (2)
Espèces
Human (2)
Étiquette
His Tag (1)Fc Tag (1)
Marqueur
Unconjugated (2)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
TRC-H5257	Human	HEK293	Human TRAC Protein, Fc Tag				Ajouter au panier
TRC-H52H3	Human	HEK293	Human TRAC Protein, His Tag				Ajouter au panier

Quantité totale2

TRACContexte de la molécule

The transmembrane protein, TCR, comprise of two disulphide-linked polypeptide chains: a α and β chain, a γ and δ chain. Each polypeptide chain consists of a variable and a constant region. TRAC is the constant region of T-cell receptor (TCR) alpha chain. TRAC is presented on the surface of T cell and recognized peptide-major histocompatibility (MH) (pMH) that are displayed by antigen presenting cells (APC). TRAC is participate in adaptive immune response and has been well-studied in T cell therapy.

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
MT-2765	MT-2765	Phase 3 Clinical	Mitsubishi Tanabe Pharma Corp	Hypertension	Details
SP-20104 (Sarfez Pharmaceuticals)	SP-20104	Phase 2 Clinical	1 A Pharma Gmbh	Glomerulosclerosis, Focal Segmental	Details
Imarikiren hydrochloride	TAK-272; SCO-272	Phase 2 Clinical	Takeda Pharmaceutical Co Ltd	Kidney Diseases; Hypertension; Diabetic Nephropathies; Hepatic Insufficiency	Details

Informations sur les médicaments commercialisés

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Plus ancien nom de marque	Pays d'approbation le plus ancien	Indication la plus ancienne	Société d'approbation la plus ancienne	Date d'approbation la plus ancienne	Indication	Essai clinique
Aliskiren Hemifumarate/Amlodipine Besilate/Hydrochlorothiazide		Approved	Novartis Pharma Ag	Rasitrio, Amturnide	United States	Hypertension	null	2010-12-21	Hypertension; Essential Hypertension	Details
Aliskiren Hemifumarate	SPP-100; SPP-100A; SPP-100B; CGP-60536; CGP-60536B	Approved	Novartis Pharma Ag	Enviage, Rasilez, Riprazo, Sprimeo, Tekturna, 锐思力	United States	Hypertension	Noden Pharma Dac	2007-03-05	Myocardial Ischemia; Heart Failure; Myocardial Infarction; Diabetes Mellitus, Type 2; Glomerulonephritis, IGA; Coronary Artery Disease; Hypertension; Hypertrophy, Left Ventricular; Diabetic macular oedema; Cardiovascular Diseases; Diabetic Nephropathies; Essential Hypertension; Overweight; Diabetes Mellitus; Kidney Failure, Chronic	Details
Aliskiren		Approved			Mainland China	Essential Hypertension	Novartis Pharma Ag	2010-03-26	Essential Hypertension	Details